Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under NRX Pharmaceuticals, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names The B Group, Inc. (filed 2025-08-21).
Who is behind it
NRX Pharmaceuticals, Inc.: incorporated in Delaware; business address in Wilmington, Delaware; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-05-15).
Officers and directors, each with the role and the filing that names them:
- Jonathan Javitt: Executive Officer, Director (Form D, 2025-03-07)
- Michael Abrams: Executive Officer (Form D, 2025-03-07)
- Patrick Flynn: Director (Form D, 2025-03-07)
- Chaim Hurvitz: Director (Form D, 2025-03-07)
- Dennis McBride: Director (Form D, 2025-03-07)
- Michael Taylor: Director (Form D, 2025-03-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-15 | Anson Funds Management LP | 4.9% |
| Schedule 13G, 2025-08-21 | The B Group, Inc. | 12.62% |
| Schedule 13G/A, 2025-08-14 | Anson Funds Management LP | 9.3% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-03-07 | $3.50M | $3.50M |
Latest IPO step: NRX Pharmaceuticals, Inc. withdrew its IPO registration (RW, 2025-06-24).
IPO filings: RW, 2025-06-24, S-1, 2024-11-14.
Trademarks: 1 application under NRX Pharmaceuticals, Inc.'s exact name, the latest AXXENYA (2026-10-08).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/nrx-pharmaceuticalsLast updated 2026-10-18
Who owns NRX Pharmaceuticals, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/nrx-pharmaceuticals